Ebola case in the US by June 30?

Resolution Criteria

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.

Prediction markets currently show the question of a confirmed Ebola case in the United States by 30 June 2026 as a low-probability but non-trivial outcome, with volume heavily concentrated on the 'No' resolution. The market resolves 'Yes' only if a laboratory-confirmed Ebola infection is identified within U.S. territory before the deadline. The CDC or an overwhelming consensus of credible reporting serves as the resolution source.

Market structure

This is a binary market with two outcomes: 'Yes' or 'No'. Volume is heavily concentrated on the 'No' side, reflecting the historical rarity of Ebola detections on U.S. soil. Resolution requires official laboratory confirmation of an active Ebola infection within U.S. territory, reported by 30 June 2026 at 11:59 PM ET. The primary resolution source is official government information, principally the CDC, with credible media consensus as a fallback.

Background

Ebola virus disease, caused by members of the Filoviridae family, has resulted in only a small number of confirmed cases ever recorded on U.S. soil. The most significant episode occurred in 2014, when a Liberian national was diagnosed in Dallas, Texas, during the West African epidemic that killed more than 11,000 people. Two healthcare workers who treated him subsequently tested positive, and several medical evacuees were treated at specialist biocontainment units. Since that outbreak was contained, no further domestically acquired or imported cases have been confirmed in the United States. Ebola remains endemic in parts of Central and East Africa, with periodic outbreaks in the Democratic Republic of Congo and neighbouring countries continuing to pose an international public health concern. U.S. screening protocols at major airports and CDC quarantine stations were reinforced following the 2014 episode.

Key factors

Several structural factors bear on whether this market resolves 'Yes'. The ongoing presence of Ebola in Central and East Africa means that traveller importation remains a persistent, if low-frequency, possibility. The volume and routing of air travel between affected regions and the United States, and the effectiveness of entry screening at U.S. ports, directly influence importation risk. The speed with which an outbreak is detected and controlled at its source affects the window during which an infectious traveller could depart. Domestic public health infrastructure — including the number of operational high-level biocontainment units and CDC rapid-response capacity — affects whether any imported case is quickly identified and contained. Geopolitical factors, including the stability of health systems in affected countries and international cooperation on outbreak response, can accelerate or delay containment. Separately, any degradation in U.S. public health surveillance or international monitoring capacity would affect both the probability of an importation and the speed of confirmation.

FAQ